Bright Minds Biosciences Inc.

NASDAQ (USD): Bright Minds Biosciences Inc. (DRUG)

Last Price

38.49

Today's Change

+36.00 (1,445.78%)

Day's Change

2.49 - 38.49

Trading Volume

98,035,273

Overview

Market Cap

171 Million

Shares Outstanding

4 Million

Avg Volume

432,596

Avg Price (50 Days)

1.16

Avg Price (200 Days)

1.33

PE Ratio

-60.14

EPS

-0.64

Earnings Announcement

27-Nov-2024

Previous Close

2.49

Open

2.62

Day's Range

2.49 - 38.49

Year Range

0.93 - 38.49

Trading Volume

98,035,273

Price Change Highlight

1 Day Change

1445.78%

5 Day Change

3531.13%

1 Month Change

2930.71%

3 Month Change

3673.53%

6 Month Change

3029.27%

Ytd Change

1991.85%

1 Year Change

2336.08%

3 Year Change

3.61%

5 Year Change

42.56%

10 Year Change

42.56%

Max Change

42.56%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment